Patents Assigned to Genesis Laboratories, Inc.
  • Publication number: 20130035303
    Abstract: The invention relates to a new rapid release oral formulation of fipronil or imidacloprid for the effective control of blood-sucking insect populations. Embodiments of the invention relate to their use by incorporation into a feed-through formulation that can be administered orally to host animals such as birds, goats, dogs, and cattle for the rapid effective control of blood sucking insects. The formulation is fast acting and the residue of the chemicals present in the feces serves as a larvacide, effectively controlling newly hatched larvae.
    Type: Application
    Filed: April 21, 2011
    Publication date: February 7, 2013
    Applicant: Genesis Laboratories, Inc.
    Inventor: Richard Poche
  • Patent number: 6264969
    Abstract: A method is described for controlling or exterminating moles through the use of a bait composition in the form of a gel, paste, or grease. The composition includes an attractant and an active ingredient capable of killing vertebrate pests. The composition is injected into a mole tunnel through a small diameter nozzle, tube or needle to avoid digging open the tunnel or causing it to collapse.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: July 24, 2001
    Assignee: Genesis Laboratories, Inc.
    Inventor: Richard M. Poche
  • Patent number: 5932437
    Abstract: A method is described for controlling the spread of Lyme Disease spirochete from rodents which have been infected. The method involves orally administering to the rodents a composition which includes an antibiotic (e.g., tetracycline) which is capable of killing the spirochete. Bait compositions are described which include an antibiotic. The bait compositions may be solid or liquid.
    Type: Grant
    Filed: April 13, 1998
    Date of Patent: August 3, 1999
    Assignee: Genesis Laboratories, Inc.
    Inventor: Richard M. Poche